We are live on ! Find out more
NSPR icon

InspireMD

26 hedge funds and large institutions have $28.7M invested in InspireMD in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

15,150% more call options, than puts

Call options by funds: $305K | Put options by funds: $2K

689% more capital inflows, than outflows

Capital inflows: $2.6M | Capital outflows: $330K

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

13% more funds holding

Funds holding: 23 → 26 (+3)

3.32% more ownership

Funds ownership: 38.01% → 41.33% (+3.3%)

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
1
Closed
2
Calls
$305K
Puts
$2K
Net Calls
+$303K
Net Calls Change
+$293K

NSPR Hedge Fund Activity: Q3 2023 in Review

26 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q3 2023, worth a combined $28.7M — up 42% from $20.2M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NSPR positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Pura Vida Investments, adding an estimated $960K. The largest seller was Nantahala Capital Management, cutting an estimated $295K.

  • 26 institutional investors held InspireMD (NSPR) as of Q3 2023, up from 23 in Q2 2023.
  • Funds reported $28.7M of InspireMD stock for Q3 2023, up 42% quarter-over-quarter.
  • 5 funds opened new InspireMD positions in Q3 2023 and 2 closed out, a net change of +3 holders.
  • The largest InspireMD buyer in Q3 2023 was Pura Vida Investments, an estimated $960K added.
  • The largest InspireMD seller in Q3 2023 was Nantahala Capital Management, an estimated $295K sold.

Based on aggregated 13F filings for Q3 2023.